Recombinant Human Epidermal Growth Factor/Quatsome Nanoconjugates: A Robust Topical Delivery System for Complex Wound Healing (Adv. Therap. 6/2021)

In article number 2000260, Jaume Veciana, Nora Ventosa and co‐workers report a soft, reliable, and scalable method based on compressed CO2 for obtaining nanoconjugates of recombinant human epidermal growth factors and nanovesicles. These nanoconjugates exhibit appropriate physicochemical properties...

Full description

Saved in:
Bibliographic Details
Published in:Advanced therapeutics 2021-06, Vol.4 (6), p.n/a
Main Authors: Ferrer‐Tasies, Lidia, Santana, Hector, Cabrera‐Puig, Ingrid, González‐Mira, Elisabet, Ballell‐Hosa, Lídia, Castellar‐Álvarez, Carla, Córdoba, Alba, Merlo‐Mas, Josep, Gerónimo, Haydee, Chinea, Glay, Falcón, Viviana, Moreno‐Calvo, Evelyn, Pedersen, Jan Skov, Romero, Jessica, Navarro‐Requena, Claudia, Valdés, Calixto, Limonta, Miladys, Berlanga, Jorge, Sala, Santiago, Martínez, Eduardo, Veciana, Jaume, Ventosa, Nora
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In article number 2000260, Jaume Veciana, Nora Ventosa and co‐workers report a soft, reliable, and scalable method based on compressed CO2 for obtaining nanoconjugates of recombinant human epidermal growth factors and nanovesicles. These nanoconjugates exhibit appropriate physicochemical properties together with an antimicrobial activity preventing infections that promote complete closure of complex wounds. Therefore, such nanoconjugates are a potential nanomedicine for the topical treatment of complex wounds, particularly diabetic foot ulcers.
ISSN:2366-3987
2366-3987
DOI:10.1002/adtp.202170011